Diagnostic efficacy and feasibility of low concentration contrast media (iodixanol) and low dose radiation in enhanced CT scans in Pediatric patients with congenital heart disease

Trial Profile

Diagnostic efficacy and feasibility of low concentration contrast media (iodixanol) and low dose radiation in enhanced CT scans in Pediatric patients with congenital heart disease

Completed
Phase of Trial: Phase IV

Latest Information Update: 08 Dec 2017

At a glance

  • Drugs Iodixanol (Primary)
  • Indications Congenital heart defects
  • Focus Diagnostic use
  • Most Recent Events

    • 08 Dec 2017 New trial record
Restricted Access

Oops, it looks like you don’t have a valid subscription to this content. To gain full access to the content and functionality of the AdisInsight database try one of the following.

  • with a username/password associated to an account with a valid subscription
  • Contact your organization’s admin about adding this content to your AdisInsight subscription
  • Request a trial

If you are a subscriber to this content then contact us at AsktheExpert.AdisInsight@springer.com so we can help.

Back to top